Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. Paredes
Observed name:
E Paredes
Institutions:
Centre Hospitalier Universitaire de Nantes,
Nantes Université
Observed institutions:
Inserm,
Institut Pasteur,
Hospital General de México,
Centre Hospitalier Universitaire de Nantes,
Centre d'Investigation Clinique de Nantes,
Universidad Nacional Autónoma de México,
Nantes Université
show all 7
ORCID:
0009-0003-8852-5126
Observed ORCID:
0009-0003-8852-5126
OpenAlex ID:
A5025488398
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinical trial
2023
·
Alexandra Compagnucci
, Man K. Chan
, et al.
·
EClinicalMedicine
·
19
PDF
Microelimination or Not? The Changing Epidemiology of Human Immunodeficiency Virus-Hepatitis C Virus Coinfection in France 2012–2018
2021
·
Laurent Cotte
, Laurent Hocqueloux
, et al.
·
Clinical Infectious Diseases
·
17
Dolutegravir-based dual maintenance regimens combined with lamivudine/emtricitabine or rilpivirine: risk of virological failure in a real-life setting
2021
·
Colin Deschanvres
, Jacques Reynes
, et al.
·
Journal of Antimicrobial Chemotherapy
·
15
Drastic Reduction in Time to Controlled Viral Load in People With Human Immunodeficiency Virus in France, 2009–2019: A Longitudinal Cohort Study
2023
·
Lise Cuzin
, Adeline Morisot
, et al.
·
Clinical Infectious Diseases
·
11
PDF
Doravirine plus lamivudine two-drug regimen as maintenance antiretroviral therapy in people living with HIV: a French observational study
2023
·
Pascale Perfezou
, Nolwenn Hall
, et al.
·
Journal of Antimicrobial Chemotherapy
·
10
PDF
Low-level viral loads and virological failure in the integrase strand transfer era
2023
·
Lise Cuzin
, Philippe Flandre
, et al.
·
Journal of Antimicrobial Chemotherapy
·
10
Hepatitis B Surface Antibody Clearance After Vaccination in People With HIV
2025
·
Axel Ursenbach
, François Séverac
, et al.
·
Open Forum Infectious Diseases
·
3
Risk Factors and Therapeutic Consequences of Virologic Failure With Long-Acting Cabotegravir Plus Rilpivirine in the Dat’AIDS Cohort
2026
·
Colin Deschanvres
, Laurent Hocqueloux
, et al.
·
Clinical Infectious Diseases
·
1
PDF
Switch to Bictegravir/Tenofovir Alafenamide/Emtrictabine or Dolutegravir + Tenofovir Disoproxil Fumarate/Emtrictabine in Virologically Suppressed People With HIV: Outcomes in Real-world Setting With and Without Tenofovir Resistance
2025
·
Alain Makinson
, Firouze Bani-Sadr
, et al.
·
Clinical Infectious Diseases
·
1
CHEMVIH :Etude sur la pratique du Chemsex chez les patients vivant avec le VIH suivis dans un service des Maladies Infectieuses et Tropicales
2025
·
B. Bonnet
, B. Schreck
, et al.
·
Médecine et Maladies Infectieuses Formation
Show more works
View as search
Works count:
10
Citation count:
87
H-index:
6
I10-index:
6
Year
Topic
Type